Overview A Study to Evaluate Safety and Efficacy of PBK_M2502 Status: NOT_YET_RECRUITING Trial end date: 2026-11-01 Target enrollment: Participant gender: Summary This clinical trial was prospective, randomized, single-blind, 3-treatment arm, parallel treatment group, and active-controlled. , Multi-center, Phase 3 confirmatory clinical trial.Phase: PHASE3 Details Lead Sponsor: Pharmbio Korea Co., Ltd.